ID

21781

Description

Olmesartan and an add-on Treatment in Patients With Mild to Moderate Hypertension; ODM derived from: https://clinicaltrials.gov/show/NCT00311155

Lien

https://clinicaltrials.gov/show/NCT00311155

Mots-clés

Versions (1)
  1. 30/04/2017 30/04/2017 -
Téléchargé le

30 avril 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Essential Hypertension NCT00311155

Anglais

Eligibility Essential Hypertension NCT00311155

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
male and female patients age greater than or equal to 18 years with mild to moderate hypertension.
Description

age, hypertension

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2]
C0020538
pre-treated patients with normal or elevated blood pressure (bp) are eligible to participate if their pre-treatment medication can be withdrawn. at the end of the placebo run-in period sitting systolic bp greater than or equal to 140 and less than 180 mmhg and/or sitting diastolic bp greater than or equal to 90 and less than 110 mmhg at trough.
Description

blood pressure, pre treatment

Type de données

boolean

Alias
UMLS CUI [1,1]
C0005823
UMLS CUI [1,2]
C2709094
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
female patients of childbearing potential must not be pregnant or lactating and must be using adequate contraception.
Description

pregnancy, breast feeding, contraception

Type de données

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3]
C0700589
patients with serious disorders which may limit the ability to evaluate the efficacy or safety of the test drug(s), including cardiovascular, renal, pulmonary, hepatic, gastrointestinal, endocrine/metabolic, haematological/oncological, neurological and psychiatric diseases.
Description

cardiovascular, renal, pulmonary, hepatic, gastrointestinal, endocrine, metabolic, hematological, oncological, neurological, neurological or psychiatric comorbidities

Type de données

boolean

Alias
UMLS CUI [1]
C0009488
UMLS CUI [2]
C0007222
UMLS CUI [3]
C0022658
UMLS CUI [4]
C0024115
UMLS CUI [5]
C0023895
UMLS CUI [6]
C0017178
UMLS CUI [7]
C0014130
UMLS CUI [8]
C0025517
UMLS CUI [9]
C0018939
UMLS CUI [10]
C0027651
UMLS CUI [11]
C0027765
UMLS CUI [12]
C0004936
patients within the last 6 months having a history of myocardial infarction, unstable angina pectoris, percutaneous coronary intervention, heart failure, cerebrovascular accident, or transient ischemic attack.
Description

myocardial infarction, unstable angina pectoris, percutaneous coronary intervention, heart failure, cerebrovascular accident, transient ischemic attack

Type de données

boolean

Alias
UMLS CUI [1]
C0027051
UMLS CUI [2]
C0002965
UMLS CUI [3]
C1532338
UMLS CUI [4]
C0018801
UMLS CUI [5]
C0038454
UMLS CUI [6]
C0007787
patients with clinically significant elevations in laboratory values at screening visit.
Description

laboratory values

Type de données

boolean

Alias
UMLS CUI [1]
C0022885
patients with secondary hypertension of any etiology, such as renal disease, pheochromocytoma, or cushing's syndrome.
Description

secondary hypertension

Type de données

boolean

Alias
UMLS CUI [1]
C0155616
patients with contraindications for olmesartan medoxomil, hydrochlorothiazide, and/or amlodipine besylate.
Description

contraindications for olmesartan medoxomil, hydrochlorothiazide or amlodipine besylate

Type de données

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C0386393
UMLS CUI [2,1]
C1301624
UMLS CUI [2,2]
C0020261
UMLS CUI [3,1]
C1301624
UMLS CUI [3,2]
C0051696
Retour au début de la page

Similar models

Eligibility Essential Hypertension NCT00311155

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
age, hypertension
Item
male and female patients age greater than or equal to 18 years with mild to moderate hypertension.
boolean
C0001779 (UMLS CUI [1])
C0020538 (UMLS CUI [2])
blood pressure, pre treatment
Item
pre-treated patients with normal or elevated blood pressure (bp) are eligible to participate if their pre-treatment medication can be withdrawn. at the end of the placebo run-in period sitting systolic bp greater than or equal to 140 and less than 180 mmhg and/or sitting diastolic bp greater than or equal to 90 and less than 110 mmhg at trough.
boolean
C0005823 (UMLS CUI [1,1])
C2709094 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
pregnancy, breast feeding, contraception
Item
female patients of childbearing potential must not be pregnant or lactating and must be using adequate contraception.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0700589 (UMLS CUI [3])
cardiovascular, renal, pulmonary, hepatic, gastrointestinal, endocrine, metabolic, hematological, oncological, neurological, neurological or psychiatric comorbidities
Item
patients with serious disorders which may limit the ability to evaluate the efficacy or safety of the test drug(s), including cardiovascular, renal, pulmonary, hepatic, gastrointestinal, endocrine/metabolic, haematological/oncological, neurological and psychiatric diseases.
boolean
C0009488 (UMLS CUI [1])
C0007222 (UMLS CUI [2])
C0022658 (UMLS CUI [3])
C0024115 (UMLS CUI [4])
C0023895 (UMLS CUI [5])
C0017178 (UMLS CUI [6])
C0014130 (UMLS CUI [7])
C0025517 (UMLS CUI [8])
C0018939 (UMLS CUI [9])
C0027651 (UMLS CUI [10])
C0027765 (UMLS CUI [11])
C0004936 (UMLS CUI [12])
myocardial infarction, unstable angina pectoris, percutaneous coronary intervention, heart failure, cerebrovascular accident, transient ischemic attack
Item
patients within the last 6 months having a history of myocardial infarction, unstable angina pectoris, percutaneous coronary intervention, heart failure, cerebrovascular accident, or transient ischemic attack.
boolean
C0027051 (UMLS CUI [1])
C0002965 (UMLS CUI [2])
C1532338 (UMLS CUI [3])
C0018801 (UMLS CUI [4])
C0038454 (UMLS CUI [5])
C0007787 (UMLS CUI [6])
laboratory values
Item
patients with clinically significant elevations in laboratory values at screening visit.
boolean
C0022885 (UMLS CUI [1])
secondary hypertension
Item
patients with secondary hypertension of any etiology, such as renal disease, pheochromocytoma, or cushing's syndrome.
boolean
C0155616 (UMLS CUI [1])
contraindications for olmesartan medoxomil, hydrochlorothiazide or amlodipine besylate
Item
patients with contraindications for olmesartan medoxomil, hydrochlorothiazide, and/or amlodipine besylate.
boolean
C1301624 (UMLS CUI [1,1])
C0386393 (UMLS CUI [1,2])
C1301624 (UMLS CUI [2,1])
C0020261 (UMLS CUI [2,2])
C1301624 (UMLS CUI [3,1])
C0051696 (UMLS CUI [3,2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial